Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients.

PLoS One · 2013 · PMC3835853 · PMID 24278166

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp<0.0001actually significant

The most striking reduction of Glucosylsphingosine occurs right after the start of therapy (47.3%, p<0.001) and within the first 6 months (47.3%), although reduction over time is also highly significant (p<0.0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.